Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer

被引:31
|
作者
Gyllensten, U. [1 ]
Sanner, K. [2 ]
Gustavsson, I. [1 ]
Lindell, M. [1 ]
Wikstrom, I. [2 ]
Wilander, E. [1 ]
机构
[1] Univ Uppsala Hosp, Dept Immunol Genet & Pathol, Rudbeck Lab, SciLifeLab, Uppsala, Sweden
[2] Uppsala Univ, Univ Uppsala Hosp, Dept Womens & Childrens Hlth, Uppsala, Sweden
关键词
cervix; screening; carcinoma; HPV test; persistence; self-sampling; HUMAN-PAPILLOMAVIRUS; WOMEN; PERSISTENCE; CLEARANCE; DEVICE; SWEDEN; COHORT; OLDER;
D O I
10.1038/bjc.2011.277
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Testing for high-risk human papillomavirus (HPV) in primary screening for cervical cancer is considered more sensitive, but less specific, in comparison with Pap-smear cytology. Women with persistent HPV infections have a higher risk of developing cervical intraepithelial neoplasia 2+ (CIN2+) lesions. This study was performed to evaluate the gain in specificity for detection of histologically confirmed CIN2+ lesions achieved by short-time repeat testing for high-risk HPV in women aged 30-65 years, with the primary sample for HPV analysis taken by self-sampling. METHODS: A total of 8000 women in Uppsala County, aged 30-65 years, who had not attended organised screening for 6 years or longer, were offered self-sampling of vaginal fluid at home and the samples sent for HPV typing. Of these, 8% (669) were not possible to contact or had performed hysterectomy. Women positive for high-risk HPV in the self-sampling test were invited for a follow-up HPV test and a cervical biopsy on average 3 months after the initial HPV test. RESULTS: In all, 39% (2850/7331) of invited women chose to perform self-sampling of vaginal fluid at home. High-risk HPV infection was found in 6.6% (188) of the women. In all, 89% of the women testing HPV positive performed a follow-up examination, on average 2.7 months, after the first test and 59% of these women were HPV positive in the follow-up test. The prevalence of CIN2+ lesions in women with an initial HPV-positive test was 23% (95% CI 18-30%) and in women with two consecutive HPV-positive tests was 41% (95% CI 31-51%). In women with two positive HPV tests, the prevalence of CIN2+ lesions varied from 49% in women at age 30-39 years to 24% in women at age 50-65 years. Short-time repeat HPV testing increased the specificity for detection of CIN2+ lesions from about 94.2% to 97.8%. The most prevalent HPV types were HPV16 (32%), followed by HPV18/45 (19%) and HPV 33/52/58 (19%). CONCLUSION: The short-time persistence of high-risk HPV infection in this age group was about 60%. Repeat testing for high-risk HPV using self-sampling of vaginal fluid can be used to increase the specificity in the screening for cervical cancer in women aged 30-65 years. British Journal of Cancer (2011) 105, 694-697. doi:10.1038/bjc.2011.277 www.bjcancer.com Published online 2 August 2011 (C) 2011 Cancer Research UK
引用
收藏
页码:694 / 697
页数:4
相关论文
共 50 条
  • [21] HPV self-sampling for cervical cancer screening: a systematic review of values and preferences
    Nishimura, Holly
    Yeh, Ping Teresa
    Oguntade, Habibat
    Kennedy, Caitlin E.
    Narasimhan, Manjulaa
    [J]. BMJ GLOBAL HEALTH, 2021, 6 (05):
  • [22] Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study
    Bertucci, Martina
    Bonnet, Emmanuel
    Satger, Laura
    Kreiche, Antoine
    Chappert, Jean-Loup
    Loy-Morel, Silvia
    Segondy, Michel
    Daures, Jean Pierre
    Boulle, Nathalie
    [J]. WOMEN & HEALTH, 2021, 61 (01) : 83 - 94
  • [23] A rapid, high-volume cervical screening project using self-sampling and isothermal PCR HPV testing
    Andrew Goldstein
    Yang Lei
    Lena Goldstein
    Amelia Goldstein
    Qiao Xu Bai
    Juan Felix
    Roberta Lipson
    Maria Demarco
    Mark Schiffman
    Didem Egemen
    Kanan T. Desai
    Sarah Bedell
    Janet Gersten
    Gail Goldstein
    Karen O’Keefe
    Casey O’Keefe
    Tierney O’Keefe
    Cathy Sebag
    Lior Lobel
    Anna Zhao
    Yan Ling Lu
    [J]. Infectious Agents and Cancer, 15
  • [24] COST-EFFECTIVENESS ANALYSIS OF CERVICAL CANCER SCREENING WITH SELF-SAMPLING FOR HUMAN PAPILLOMAVIRUS (HPV) TESTING IN TAIWAN
    Tsai, B. C.
    Chow, I. H. I.
    Liao, C. H.
    You, S. L.
    Tang, C. H.
    Pwu, R. F.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A656 - A657
  • [25] A rapid, high-volume cervical screening project using self-sampling and isothermal PCR HPV testing
    Goldstein, Andrew
    Lei, Yang
    Goldstein, Lena
    Goldstein, Amelia
    Bai, Qiao Xu
    Felix, Juan
    Lipson, Roberta
    Demarco, Maria
    Schiffman, Mark
    Egemen, Didem
    Desai, Kanan T.
    Bedell, Sarah
    Gersten, Janet
    Goldstein, Gail
    O'Keefe, Karen
    O'Keefe, Casey
    O'Keefe, Tierney
    Sebag, Cathy
    Lobel, Lior
    Zhao, Anna
    Lu, Yan Ling
    [J]. INFECTIOUS AGENTS AND CANCER, 2020, 15 (01)
  • [26] HPV self-sampling as an additional option in cervical cancer screening: a pilot study in Estonia
    Hallik, R.
    Innos, K.
    Janes, J.
    Veerus, P.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 32
  • [27] HPV self-sampling: A promising approach to reduce cervical cancer screening disparities in Canada
    Vahabi, M.
    Lofters, A.
    [J]. CURRENT ONCOLOGY, 2018, 25 (01) : 13 - 18
  • [28] HPV prevalence and acceptability of HPV self-sampling for cervical cancer screening in the community of Santiago Atitlan, Guatemala
    Gottschlich, Anna
    Meza, Rafael
    -Andrade, Alvaro Rivera
    Grajeda, Edwin
    Alvarez, Christian
    Montano, Carlos Mendoza
    [J]. CANCER RESEARCH, 2016, 76
  • [29] Self-sampling HPV DNA test for cervical cancer screening in Singapore: A prospective study
    Lim, Li Min
    Chan, Ming Fen Grace
    Win, Pa Pa Thu
    Shen, Liang
    Arunachalam, Ilancheran
    Ng, Soon Yau Joseph
    Low, Jen Hui Jeffrey
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2022, 51 (11) : 733 - 735
  • [30] HPV self-sampling among cervical cancer screening nonattenders: a feasibility study in Estonia
    Hallik, R.
    Innos, K.
    Janes, J.
    Veerus, P.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31